Education
About Us
Working with TipRanks
Follow Us
Arcadia Biosciences (RKDA)
NASDAQ:RKDA
RKDA Stock Chart & Stats
Day’s Range― - ―
52-Week Range$2.53 - $10.31
Previous CloseN/A
Volume12.29K
Average Volume (3M)10.30K
Market Cap
$4.74M
Enterprise Value$1.46M
Total Cash (Recent Filing)$3.16M
Total Debt (Recent Filing)$21.00K
Price to Earnings (P/E)―
Beta1.45
Next Earnings
Nov 12, 2025EPS Estimate
-0.54Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.26
Shares Outstanding1,367,040
10 Day Avg. Volume6,892
30 Day Avg. Volume10,300
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap0.31
Enterprise Value/Revenue0.28
Enterprise Value/Gross Profit0.70
Enterprise Value/Ebitda-0.27
Forecast
1Y Price Target
$12.00Price Target Upside245.82% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Bulls Say, Bears Say
Bulls Say
Financial PerformanceQ4’24 results were ahead of expectations behind Zola coconut water growth of 124% via an 86% distribution increase.
Market ExpansionZola’s 80% distribution expansion in 2024 to approximately 3,000 stores is providing considerable visibility for year-over-year growth.
Bears Say
Portfolio MonetizationManagement noted they continue to seek further monetization of legacy ag biotech IP and expect a series of transactions to unwind this portfolio.
Valuation ConcernArcadia's current valuation levels are considered materially depressed relative to a post-merger fair value, making it an attractive option for special situation and/or merger arbitrage investors.
Arcadia Biosciences News
RKDA FAQ
What was Arcadia Biosciences’s price range in the past 12 months?
Arcadia Biosciences lowest stock price was $2.53 and its highest was $10.31 in the past 12 months.
What is Arcadia Biosciences’s market cap?
Arcadia Biosciences’s market cap is $4.74M.
When is Arcadia Biosciences’s upcoming earnings report date?
Arcadia Biosciences’s upcoming earnings report date is Nov 12, 2025 which is in 36 days.
How were Arcadia Biosciences’s earnings last quarter?
Arcadia Biosciences released its earnings results on Aug 14, 2025. The company reported -$3.26 earnings per share for the quarter, missing the consensus estimate of -$0.79 by -$2.47.
Is Arcadia Biosciences overvalued?
According to Wall Street analysts Arcadia Biosciences’s price is currently Undervalued.
Does Arcadia Biosciences pay dividends?
Arcadia Biosciences does not currently pay dividends.
What is Arcadia Biosciences’s EPS estimate?
Arcadia Biosciences’s EPS estimate is -0.54.
How many shares outstanding does Arcadia Biosciences have?
Arcadia Biosciences has 1,367,040 shares outstanding.
What happened to Arcadia Biosciences’s price movement after its last earnings report?
Arcadia Biosciences reported an EPS of -$3.26 in its last earnings report, missing expectations of -$0.79. Following the earnings report the stock price went up 5.682%.
Which hedge fund is a major shareholder of Arcadia Biosciences?
Currently, no hedge funds are holding shares in RKDA
Company Description
Arcadia Biosciences
Arcadia Biosciences, Inc. produces and markets plant-based health and wellness products in the United States. It engages in developing crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health and wellness products, and their viability for industrial applications. The company was incorporated in 2002 and is headquartered in Davis, California.
RKDA Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflected a strong start to 2025, with significant revenue growth in the Zola brand and effective cost control measures. However, challenges such as a decline in gross margin and an increase in inventory and cash consumption were noted. The pending business combination with Roosevelt Resources is a positive development, enhancing future prospects.View all RKDA earnings summariesRKDA Stock 12 Month Forecast
Average Price Target
$12.00
▲(245.82% Upside)
Technical Analysis
American Vanguard
―
Origin Agritech
―
BioHarvest Sciences
―
Bioceres Crop Solutions
―
Lavoro Limited
―
Ownership Overview
0.40% Insiders
1.78% Mutual Funds
0.02% Other Institutional Investors
97.09% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---